Nuvation Bio Inc.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	4	+1.65M	96.7%	$2.44	+$4.03M
Sells	1	-56.4K	3.3%	$2.89	-$163K
Net	+3	+1.59M	93.4%		+$3.86M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Omega Fund V, L.P.	10%+ Owner	$115M			Apr 5, 2022
David Hung	PRESIDENT AND CEO, Director, 10%+ Owner	$95.5M	+$820K	+0.87%	Apr 4, 2025
Xiangmin Cui	Director	$77.1M	+$2.32M	+3.1%	Sep 3, 2024
Junyuan Jerry Wang	CEO, ANHEART THERAPEUTICS LTD., Director	$17.7M	-$163K	-0.91%	Nov 11, 2024
Oleg Nodelman	Director	$17.3M			Sep 19, 2023
Daniel G. Welch	Director	$1.08M			May 24, 2024
Kim D. Blickenstaff	Director	$500K	+$500K		Sep 3, 2024
Robert Mashal	Director	$334K	+$387K		Apr 1, 2025
Colleen Sjogren	Chief Commercial Officer	$80.9K			Feb 28, 2025
David C. Hanley	Chief Technical Operations	$52K			Feb 28, 2025
Stacy Markel	Chief People Officer	$47.9K			Feb 28, 2025
Moses Makunje	Title: VP, Finance and principal financial and accounting officer.	$44.1K			Feb 28, 2025
Dongfang Liu	Chief Medical Officer	$34.7K			Feb 28, 2025
Jennifer A. Fox	Chief Financial Officer	$6.1K			Feb 28, 2023
Robert B. Bazemore	Director				Sep 3, 2024
Philippe Sauvage	Chief Financial Officer				Feb 28, 2025
Kathryn E. Falberg	Director				Sep 3, 2024
Kerry Wentworth	Chief Regulatory Officer				Feb 28, 2025
W. Anthony Vernon	Director				Sep 3, 2024
Gary Hattersley	Chief Scientific Officer				Feb 28, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.